Skip to main content
PURE
OTC Industrial Applications And Services

PURE Bioscience FY2026: Sales Up 5% to $2.32M, Net Loss Widens to $2.48M, $1.0M of Related-Party Notes Past Due

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Household Product Stocks · Consumer
Sentiment info
Negative
Importance info
7
Price
$0.079
Mkt Cap
$10.206M
52W Low
$0.039
52W High
$0.1
52W Position info
103% above low
Off High info
21% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

PURE has more than doubled off its 52-week low of $0.039 on light trading volume (0.2× avg).

Summary

PURE Bioscience reported fiscal 2026 sales of $2.32 million, up 5%, but the net loss widened to $2.48 million and it ended the year with $569,000 of cash against $1.0 million of past-due related-party convertible notes.


Key Events · Earnings and Guidance · PURE

  • FY2026 Sales Rise 5% to $2.32M

    Net product sales were $2,315,000 versus $2,198,000 a year earlier, a $117,000 increase attributed to higher sales across the end-user network.

  • Net Loss Widens to $2.48M

    Net loss was $2,483,000 versus $2,399,000 in fiscal 2025; the prior year was helped by $175,000 from the Employee Retention Tax Credit Program. Net cash used in operations was $1,970,000.

  • Liquidity Thin, Related-Party Notes Past Due

    Cash was $569,000 at July 31, 2026 against $7,592,000 of total liabilities, including $3,381,000 of current convertible notes to related parties of which $1,015,000 is past due. Stockholders' deficiency was $6,399,000.

  • Share Count and Authorization Both Raised

    Shares outstanding rose to 130,017,569 from 111,886,473, and authorized common stock was increased to 250,000,000 from 200,000,000 — leaving roughly 120 million authorized-but-unissued shares.


Analysis · PURE · Industrial Applications And Services

A $117,000 revenue increase was not enough to cover a $3.4 million operating cost base, so the net loss widened to $2.48 million and cash used in operations reached $1.97 million. The company closed the year with only $569,000 of cash against $7.6 million of total liabilities, including $3.38 million of convertible notes owed to related parties, of which $1,015,000 is already past due. That combination — thin liquidity, past-due related-party debt, and a stockholders' deficit of $6.4 million — keeps the going-concern pressure previously disclosed in the June 10-Q squarely in place and makes another dilutive raise likely; already, on 2026-10-20, the company sold 10.18 million shares at $0.0545 for $555,000 to director Tom Y. Lee and affiliates.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PURE was trading at $0.08 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $10.2M. The 52-week trading range was $0.04 to $0.10. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PURE - Latest Insights

PURE
Oct 29, 2026, 4:10 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $0.0785
Real-time Price: $0.070 info
Change: -$0.0085 (-11%) info
Market Cap: $9.814M info
PURE
Oct 20, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.072
Real-time Price: $0.070 info
Change: -$0.0020 (-3%) info
Market Cap: $9.814M info
PURE
Jun 15, 2026, 4:21 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.070
Real-time Price: $0.070 info
Change: $0 (0%) info
Market Cap: $9.814M info
PURE
Jun 15, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.070
Real-time Price: $0.070 info
Change: $0 (0%) info
Market Cap: $9.814M info
PURE
Jun 15, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.070
Real-time Price: $0.070 info
Change: $0 (0%) info
Market Cap: $9.814M info